Currency Exchange International, Corp.
CURN
$14.95
$0.000.00%
| Weiss Ratings | CURN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Risk Index | Weak | |||
| Risk Grade | D+ | |||
| Reward Grade | C | |||
| Rating Factors | CURN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Good | |||
| Solvency Index | Excellent | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | CURN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.21 | |||
| Price History | CURN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -0.66% | |||
| 30-Day Total Return | -2.80% | |||
| 60-Day Total Return | -5.97% | |||
| 90-Day Total Return | -18.68% | |||
| Year to Date Total Return | -6.56% | |||
| 1-Year Total Return | -16.34% | |||
| 2-Year Total Return | -16.81% | |||
| 3-Year Total Return | 49.35% | |||
| 5-Year Total Return | 39.07% | |||
| 52-Week High % Change | -25.95% | |||
| 52-Week Low % Change | 1.70% | |||
| Price | CURN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $20.19 | |||
| 52-Week Low Price | $14.70 | |||
| 52-Week Low Price (Date) | Mar 11, 2025 | |||
| 52-Week High Price (Date) | Sep 10, 2024 | |||
| Valuation | CURN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 93.98M | |||
| Enterprise Value | 6.27M | |||
| Price/Earnings (TTM) | 43.71 | |||
| Earnings Per Share (TTM) | 0.34 | |||
| Earnings Per Share Growth | -77.35% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 1.08 | |||
| Price/Book (Q) | 1.21 | |||
| Enterprise Value/Revenue (TTM) | 0.07 | |||
| Price | $14.95 | |||
| Enterprise Value/EBITDA (TTM) | 0.37 | |||
| Enterprise Value/EBIT | 0.41 | |||
| Market Cap Category | Micro Cap | |||
| Dividends and Shares | CURN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 6.16M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | CURN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 407-240-0224 | |||
| Address | 6649 Westwood Boulevard Orlando, FL 32821 | |||
| Website | www.ceifx.com | |||
| Country | United States | |||
| Year Founded | 1998 | |||
| Profitability | CURN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 18.12% | |||
| Profit Margin | 2.90% | |||
| Management Effectiveness | CURN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 7.34% | |||
| Return on Equity | 3.12% | |||
| Income Statement | CURN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 85.24M | |||
| Total Revenue (TTM) | 85.24M | |||
| Revenue Per Share | $13.84 | |||
| Gross Profit (TTM) | 83.65M | |||
| EBITDA (TTM) | 16.82M | |||
| EBIT (TTM) | 15.45M | |||
| Net Income (TTM) | 2.47M | |||
| Net Income Avl. to Common (TTM) | 2.47M | |||
| Total Revenue Growth (Q YOY) | 1.15% | |||
| Earnings Growth (Q YOY) | -222.32% | |||
| EPS Diluted (TTM) | 0.34 | |||
| EPS Diluted Growth (Q YOY) | -234.53% | |||
| Balance Sheet | CURN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 101.88M | |||
| Cash Per Share (Q) | $16.54 | |||
| Total Current Assets (Q) | 118.51M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 79.39M | |||
| Current Ratio (Q) | 2.654 | |||
| Book Value Per Share (Q) | $12.32 | |||
| Total Assets (Q) | 131.16M | |||
| Total Current Liabilities (Q) | 44.66M | |||
| Total Debt (Q) | 11.34M | |||
| Total Liabilities (Q) | 51.77M | |||
| Total Common Equity (Q) | 79.39M | |||
| Cash Flow | CURN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -3.00M | |||
| Cash from Financing (TTM) | -14.32M | |||
| Net Change in Cash (TTM) | 9.16M | |||
| Levered Free Cash Flow (TTM) | 26.83M | |||
| Cash from Operations (TTM) | 26.67M | |||
